Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of Thoracic Surgery

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ATHORACSUR.2004.04.085PMID 15464470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.

  2003cited by this paper
• PL-4 Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): First outcome analysis of North American Intergroup trial 0139 (RTOG 93-09)

  2003cited by this paper
• Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy.

  2001cited by this paper
• The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors.

  2000cited by this paper
• Radiation and chemotherapy for patients with stage III non-small cell lung cancer.

  2000cited by this paper
• Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.

  2000cited by this paper
• Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.

  1999cited by this paper
• Safe pulmonary resection after chemotherapy and high-dose thoracic radiation.

  1999cited by this paper
• Multimodality therapy in stage III non-small cell lung cancer.

  1996cited by this paper
• Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

  1995cited by this paper
• Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group.

  1995cited by this paper
• Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non‐small cell lung cancer

  1994cited by this paper
• Postoperative complications after combined neoadjuvant treatment of lung cancer.

  1993cited by this paper
• Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.

  1993cited by this paper
• A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.

  1990cited by this paper
• The role of surgery in N2 lung cancer.

  1987cited by this paper
• Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

  1987cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• CRES3T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumors.

  2025cites this paper
• Initial single-institutional experience with salvage surgery for stage IV non-small-cell lung cancer

  2025cites this paper
• Genetic Alteration Profiling in North Macedonian Lung Cancer Patients

  2025cites this paper
• A retrospective analysis of neoadjuvant chemotherapy in pneumonectomy for locally advanced central non–small cell lung cancer

  2025cites this paper
• Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review

  2025cites this paper
• The Role of Combined C-reactive Protein and Albumin Indices in Predicting Prolonged Hospital Stay in Acute Pancreatitis: A Prospective Observational Study

  2025cites this paper
• Integrative Approaches in Non-Small Cell Lung Cancer Management: The Role of Radiotherapy

  2024cites this paper
• Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.

  2023cites this paper
• The Role of Salvage Surgery After Definitive Radiation for Non-small-cell Lung Cancer.

  2023cites this paper
• ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer.

  2023cites this paper
• Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery

  2023cites this paper
• Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage III Non-Small Cell Lung Cancer

  2023cites this paper
• Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?

  2021cites this paper
• Optimal surgical timing and radiotherapy dose for trimodality therapy in locally advanced non‐small cell lung cancer

  2021cites this paper
• Major pulmonary resection after neoadjuvant chemotherapy or chemoradiation in potentially resectable stage III non-small cell lung carcinoma

  2021cites this paper
• Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy.

  2021cites this paper
• Salvage Surgery Compared to Surgery After Induction Chemoradiation Therapy for Advanced Lung Cancer.

  2021cites this paper
• Radiation Oncology of Lung Cancer: Why We Fail(ed) in Clinical Research?

  2021cites this paper
• Multimodality Treatment of Stage IIIA/N2 NSCLC: Why Always NO to Surgery?

  2021cites this paper
• Major Pulmonary Resection After Neoadjuvant Therapy in Potentially Resectable Stage IIIA/B Non-Small Cell Lung Carcinoma: R0 or No R0

  2021cites this paper
• Development of a nomogram for predicting the operative mortality of patients who underwent pneumonectomy for lung cancer: a population-based analysis

  2020cites this paper
• Heterogeneity of stage IIIA non-small cell lung cancer—different tumours, different nodal status, different treatment, different prognosis: a narrative review

  2020cites this paper
• Is Resection of Persistent N2 Disease After Induction Therapy Effective?

  2020cites this paper
• Prognostic significance of pathological complete response in non-small cell lung cancer following neoadjuvant treatment.

  2020cites this paper
• Tri-modality versus chemoradiation and salvage resection in cN2 stage IIIA Non-Small Cell Lung Cancer.

  2020cites this paper
• Locally advanced non-small cell lung cancer: the place of specialist thoracic surgery in the multidisciplinary team

  2020cites this paper
• Primary pneumonectomy, pneumonectomy after induction therapy, and salvage pneumonectomy: a comparison of surgical and prognostic outcomes

  2020cites this paper
• Salvage surgery after chemotherapy and/or radiotherapy including SBRT and proton therapy: A consecutive analysis of 38 patients.

  2020cites this paper
• Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer.

  2020cites this paper
• The outcome of patients treated with salvage surgery after chemo-radiotherapy for locally advanced non-small cell lung carcinoma

  2020cites this paper
• Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment

  2020cites this paper
• The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study

  2020cites this paper
• Stage IIIA Pathologic N2 Non-Small Cell Lung Cancer Patients May Maximize Benefit from Preoperative Radiotherapy: A Population-Based Study

  2020cites this paper
• Bronchopleural Fistulae

  2019cites this paper
• Bronchus anastomosis healing depending on type of neoadjuvant therapy.

  2019cites this paper
• Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer.

  2019cites this paper
• Salvage surgery for small cell lung cancer after chemoradiotherapy

  2019cites this paper
• Salvage surgery after chemo- or chemoradiotherapy for initially unresectable lung carcinoma.

  2019cites this paper
• Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis

  2018cites this paper
• Preoperative radiation may improve the outcomes of resectable IIIA/N2 non‐small‐cell lung cancer patients: A propensity score matching‐based analysis from surveillance, epidemiology, and end results database

  2018cites this paper
• Advanced VATS resections: radiation therapy and VATS

  2018cites this paper
• Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer.

  2018cites this paper
• Lung Cancer and Other Thoracic Malignancies

  2017cites this paper
• Intra- and Extra-Thoracic Muscle Flaps and Chest Wall Reconstruction Following Resection of Thoracic Tumors.

  2017cites this paper
• Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer.

  2017cites this paper
• Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality Strategy.

  2017cites this paper
• Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers

  2017cites this paper
• Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839

  2017cites this paper
• Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.

  2017cites this paper
• Long-term survival results of non-small cell lung cancer patients with complete pathological response after neoadjuvant therapy

  2016cites this paper
• Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis.

  2016cites this paper
• Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer

  2016cites this paper
• Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.

  2016cites this paper
• Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature

  2016cites this paper
• Delineation of clinical target volume for postoperative radiotherapy in stage iiiA-pN2 non-small-cell lung cancer

  2016cites this paper
• ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer

  2015cites this paper
• Associations Between Personal Cancer History and Lung Cancer Risk

  2015influential citation
• Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment.

  2015cites this paper
• Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

  2015cites this paper
• Neoadjuvant radiotherapy/chemoradiotherapy in locally advanced non-small cell lung cancer.

  2015cites this paper
• Higher Versus Standard Preoperative Radiation in the Trimodality Treatment of Stage IIIa Lung Cancer.

  2015cites this paper
• Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.

  2015cites this paper
• Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.

  2015cites this paper
• Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis.

  2015cites this paper
• A Patient Who Underwent Resection of Squamous Cell Lung Cancer Which Arose in a Previously Irradiated Field of Small Cell Lung Cancer (SCLC)

  2015cites this paper
• Surgical management of advanced non-small cell lung cancer.

  2014cites this paper
• NCCN Guidelines Version 1.2015 Panel Members Non-Small Cell Lung Cancer

  2014cites this paper
• NCCN Non – Small Cell Lung Cancer , Version 1 . 2015 Clinical Practice Guidelines in Oncology

  2014cites this paper
• Bronchial stump closure with amniotic membrane in animal model

  2014cites this paper
• Video-Assisted (VATS) Lobectomy After Induction Therapy

  2014cites this paper
• Surgical resection of non-small cell lung cancer with N2 disease.

  2014cites this paper
• Video-assisted thoracoscopic (VATS) lobectomy after induction therapy.

  2014cites this paper
• Non-small cell lung cancer, version 1.2015.

  2014cites this paper
• Surgery for Isolated Metachronous Thyroid Metastasis in a Non-small Cell Lung Carcinoma Patient with Hashimoto's Thyroiditis: A Case Report

  2014cites this paper
• Surgical Approach to Locally Advanced Non-Small Cell Lung Cancer

  2013cites this paper
• Uniportal video-assisted thoracoscopic lobectomy: two years of experience.

  2013cites this paper
• Induction and Adjuvant Therapy for N 2 NSCLC EVIDENCE TABLE

  2013cites this paper
• Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens.

  2013cites this paper
• Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival.

  2013cites this paper
• Non-small Cell Lung Cancer

  2013cites this paper
• Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes.

  2013cites this paper
• Pneumonectomy with and without induction chemo-radiotherapy for non-small cell lung cancer: short and long-term results from a single centre.

  2013cites this paper
• INDUCTION AND ADJUVANT THERAPY FOR N2 NON-SMALL-CELL LUNG CANCER

  2013cites this paper
• [National consensus of diagnosis and treatment of non-small cell lung cancer].

  2013cites this paper
• Neoadjuvant chemoradiotherapy for stage III (N2/3) non-small-cell lung cancer: a review of prospective studies

  2013cites this paper
• Nonsmall Cell Lung Cancer Pneumonectomy After High-Dose Radiation and Concurrent Chemotherapy for

  2013cites this paper
• The role of surgery in patients with clinical n2 disease.

  2013cites this paper
• Induction and Adjuvant Therapy for N 2 NSCLC EVIDENCE TABLE

  2013cites this paper
• [Chemo-radiotherapy before surgery in stage III non-small-cell lung cancer].

  2013cites this paper
• AP-PA field orientation followed by IMRT reduces lung exposure in comparison to conventional 3D conformal and sole IMRT in centrally located lung tumors

  2012cites this paper
• Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer.

  2012cites this paper
• Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.

  2012cites this paper
• Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.

  2012cites this paper
• Pathological status of mediastinal lymph nodes after preoperative concurrent chemoradiotherapy determines prognosis in patients with non-small cell lung cancer.

  2012cites this paper
• Vinorelbine-Based Chemo-Radiotherapy in Non-Small Cell Lung Cancer

  2012cites this paper
• Does Dose Matter? Effect of Two Different Neoadjuvant Protocols in Advanced NSCLC

  2012cites this paper
• The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.

  2012cites this paper
• Case Study : Evolving Surgical Strategies for the Management of the Peripheral Lung Nodule Suspicious for Cancer

  2012cites this paper
• Risk Factors for Bronchopleural Fistula After Right Pneumonectomy: Does Eliminating the Stump Diverticulum Provide Protection?

  2012cites this paper
• Lung cancer staging: pathology issues.

  2012cites this paper